The global smart syringes market is set for robust growth, with an estimated size of USD 1.05 billion in 2024 and a projection to reach USD 2.22 billion by 2033. This represents a ...

The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

The use of injectable peptides for a range of perceived health benefits is surging, fueled by aggressive marketing campaigns and miraculous claims from celebrities and influencers about their ability ...

A research team led by scholars from Zhejiang University in East China has achieved the world's first non-invasive delivery ...

Novo Nordisk A/S is rated a Strong Buy with a huge unmet demand in obesity treatment and a low 13x P/E ratio. Learn more ...

Chinese researchers recently achieved the world's first non-invasive insulin delivery through skin, resulting in a blood sugar-lowering effect comparable to regular insulin injections.

In mice with type 1 diabetes, a topical dose of OP-I was smeared onto the skin. Blood glucose levels fell to a normal range ...

A groundbreaking polymer-based skin cream shows promise in replacing painful daily insulin injections for diabetes management ...

Argentina diabetes devices market was valued at US$ 539.12 million in 2024 and is projected to hit the market valuation of US$ 1,031.89 million by 2033 at a CAGR of 7.48% during the forecast period ...

Corp., a large manufacturer of insulin injection devices, has expanded its partnership with Direct Relief, a leading humanitarian aid organization and large charitable insulin provider in the ...